APx Acquisition Corp. I (APXI)
(Delayed Data from NSDQ)
$11.55 USD
+0.01 (0.09%)
Updated May 31, 2024 03:59 PM ET
After-Market: $11.55 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
APXI 11.55 +0.01(0.09%)
Will APXI be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for APXI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for APXI
APx Acquisition Corp. I, OmnigenicsAI Corp and MultiplAI Health Ltd enter into Business Combination Agreement to create a global AI-driven genomics platform
APx Acquisition Corp. I Announces Strategic Triple Merger
OmnigenicsAI set to go public via SPAC merger agreement
APx Acquisition Corp. I signs BCA for AI-driven genomics platform